These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 21394033)

  • 1. Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: results of a claims data-based 1-year follow-up.
    van den Bussche H; Kaduszkiewicz H; Koller D; Eisele M; Steinmann S; Glaeske G; Wiese B
    Int Clin Psychopharmacol; 2011 Jul; 26(4):225-31. PubMed ID: 21394033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eight-year prescription trends of memantine and cholinesterase inhibitors among persons 65 years and older in Germany.
    Hoffmann F; van den Bussche H; Glaeske G; Kaduszkiewicz H
    Int Clin Psychopharmacol; 2010 Jan; 25(1):29-36. PubMed ID: 19934763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer).
    Tifratene K; Duff FL; Pradier C; Quetel J; Lafay P; Schück S; Benzenine E; Quantin C; Robert P
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):1005-12. PubMed ID: 22718684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary care physicians' attitudes related to cognition enhancers in early dementia: a representative eight-year follow-up study in Lower Saxony, Germany.
    Maeck L; Haak S; Knoblauch A; Stoppe G
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):415-21. PubMed ID: 17907276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous treatment with antidementia drugs in Germany 2003-2013: a retrospective database analysis.
    Bohlken J; Weber S; Rapp MA; Kostev K
    Int Psychogeriatr; 2015 Aug; 27(8):1335-42. PubMed ID: 25899936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Australian population trends and disparities in cholinesterase inhibitor use, 2003 to 2010.
    Zilkens RR; Duke J; Horner B; Semmens JB; Bruce DG
    Alzheimers Dement; 2014 May; 10(3):310-8. PubMed ID: 23849590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment strategies of residential primary care providers in dementia diseases--results of a representative survey in western Austria.
    Gurka P; Bacher R; Kemmler G; Hinterhuber H; Lingg A; Marksteiner J
    Pharmacopsychiatry; 2002 Jul; 35(4):144-9. PubMed ID: 12163984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of prescriptions issued by nursing home-based physicians versus office-based physicians for frail elderly patients in German nursing homes.
    Pittrow D; Krappweis J; Rentsch A; Schindler C; Hach I; Bramlage P; Kirch W
    Pharmacoepidemiol Drug Saf; 2003; 12(7):595-9. PubMed ID: 14558183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prescription differences of dementia drugs in urban and rural areas in Germany].
    Bohlken J; Selke GW; van den Bussche H
    Psychiatr Prax; 2011 Jul; 38(5):232-6. PubMed ID: 21425036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do we treat people with dementia in Croatia.
    Mimica N; Presecki P
    Psychiatr Danub; 2010 Jun; 22(2):363-6. PubMed ID: 20562784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 13. Memantine for treatment of moderate to severe Alzheimer's disease.
    Perras C
    Issues Emerg Health Technol; 2005 Mar; (64):1-4. PubMed ID: 15762015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is physician adherence to prescription guidelines a general trait of health care practices or dependent on drug type?--a multilevel logistic regression analysis in South Sweden.
    Ohlsson H; Merlo J
    Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):682-90. PubMed ID: 19437457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of prescription practices and of the rational use of medicines in Niger].
    Mallet HP; Njikam A; Scouflaire SM
    Sante; 2001; 11(3):185-93. PubMed ID: 11641083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for dementia: the first year. An audit of prescribing practice.
    McGirr G; Compton SA
    Ulster Med J; 2000 Nov; 69(2):123-7. PubMed ID: 11196723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical practice with antidementia drugs in a geriatric clinic.
    Rungsanpanya T; Muangpaisan W; Praditsuwan R
    J Med Assoc Thai; 2012 Aug; 95(8):1081-9. PubMed ID: 23061314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The burden of psychotropic drug prescribingin people with dementia: a populationdatabase study.
    Guthrie B; Clark SA; McCowan C
    Age Ageing; 2010 Sep; 39(5):637-42. PubMed ID: 20625185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.